webmaster – Activate Therapeutics

April 12, 2023 In Uncategorized By webmaster

Mark Moody, Ph.D. of Activate will present at the STING&TLR-Targeting Therapies conference

Mark Moody, Ph.D. of Activate will present “Nanomedicine Formulations for Delivery of TLR Agonist Drug Combinations” at the May 9-11 STING&TLR-Targeting Therapies conference in Boston.

January 11, 2023 In Uncategorized By webmaster

Activate presents at the 2023 Biotech Showcase

Brian Horsburgh, Activate’s CEO, presented on the company’s technology and pipeline at the Biotech Showcase in San Francisco.

August 29, 2022 In News By webmaster

Mark Moody, Ph.D. of Activate Presents at STING&TLR-Targeting Therapies conference

Mark Moody, Ph.D. of Activate presented “Nanomedicine Formulations for TLR Agonist Drug Combinations” at the March 22-24 STING&TLR-Targeting Therapies conference.